Cite
The lactate receptor GPR81 mediates hepatic lipid metabolism and the therapeutic effect of metformin on experimental NAFLDs.
MLA
Wu, Guanglu, et al. “The Lactate Receptor GPR81 Mediates Hepatic Lipid Metabolism and the Therapeutic Effect of Metformin on Experimental NAFLDs.” European Journal of Pharmacology, vol. 924, June 2022, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.ejphar.2022.174959.
APA
Wu, G., Dai, Y., Yan, Y., Zheng, X., Zhang, H., Li, H., & Chen, W. (2022). The lactate receptor GPR81 mediates hepatic lipid metabolism and the therapeutic effect of metformin on experimental NAFLDs. European Journal of Pharmacology, 924, N.PAG. https://doi.org/10.1016/j.ejphar.2022.174959
Chicago
Wu, Guanglu, Yufeng Dai, Yongheng Yan, Xu Zheng, Hao Zhang, Haitao Li, and Wei Chen. 2022. “The Lactate Receptor GPR81 Mediates Hepatic Lipid Metabolism and the Therapeutic Effect of Metformin on Experimental NAFLDs.” European Journal of Pharmacology 924 (June): N.PAG. doi:10.1016/j.ejphar.2022.174959.